Private equity firms Fountainvest Capital Partners, TPG and Warburg Pincus are among final-round bidders for Carlyle Group’s stake in AmbioPharm Inc, people with knowledge of the transaction told Reuters. Carlyle...
Pharmaceutical
Piramal, Cadila among 32 companies in race to buy Sharon Bio-Medicine
Piramal Pharma, Cadila Pharmaceuticals, Shamrock Pharmachemi and ACG Associated Capsules are among the 32 entities in the fray to acquire Sharon Bio-Medicine, which is undergoing a second round of insolvency...
CCI clears deal involving Sekhmet Pharmaventures, Optimus Drugs
The Competition Commission of India approved the proposed deal involving Sekhmet Pharmaventures and Optimus Drugs Pvt Ltd. Under the transaction, Sekhmet would buy a majority shareholding in Optimus Drugs. The fair...
NCLT approves demerger of pharma business from Piramal Enterprises
The National Company Law Tribunal on Friday approved the demerger of Piramal Enterprises’ (PEL) pharma business and the simplification of the company’s corporate structure. The order paves the way towards creation of...
Advent to sell Bioduro stake, eyes valuation over $1 bln – sources
Buyout firm Advent International plans to sell a majority stake in U.S.-based Bioduro-Sundia in a deal that could value the drug development and manufacturing outsourcing provider at over $1 billion, said three people...
Intas & Dr Reddy’s in race with PEs to buy US’ Athenex
India’s Intas Pharmaceuticals and Dr Reddy’s Laboratories are in talks to acquire Athenex Inc in a $200-250 million (₹1,580-1,980 crore) deal, as the US-based biotechnology firm looks to sell a controlling...
LIC reduces stake by 2% in Sun Pharma to 5.024%
Life insurance giant, LIC on Monday announced offloading of a portion of its stake in pharma major, Sun Pharmaceuticals Industries. LIC has trimmed its stake by 2.002% in the pharma company. Both LIC and Sun Pharma...
GSK spins off $36 billion consumer-healthcare business Haleon
GSK PLC completed the spinoff of its consumer-healthcare business, a bet that greater focus on innovative drugs and vaccines will help accelerate growth at the pharmaceuticals giant. The new stand-alone company, called...
Piramal Enterprises gets shareholders’ nod to demerge pharma business
Ajay Piramal-owned Piramal Enterprises has received shareholders’ approval to demerge its pharmaceuticals business and simplify the corporate structure. The company received 99 per cent of the votes at the shareholders...
Merck in advanced talks to buy Seagen in nearly $40-bln deal – WSJ
Drugmaker Merck & Co is in advanced talks to buy cancer-focused biotech company Seagen Inc in a deal that could be worth roughly $40 billion or more, the Wall Street Journal reported. The companies are discussing a...
Brazilian pharma Hypera in merger talks with Grupo NC – media report
Brazilian drugmaker Hypera SA is in talks to merge with conglomerate Grupo NC, according to a Tuesday report from business newspaper Valor Economico. Under the potential deal, Hypera would become part of Grupo NC, which...
Walgreens defers Boots UK sale; Reliance to look for other opportunities
American retail major Walgreens Boots Alliance on Tuesday said it would retain its pharma retail business — Boots UK — thus abandoning the entire sale process. The company did not make any comment specifically on the...
